| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
X4 Pharmaceuticals (NASDAQ:XFOR) reported its Q4 earnings results on Thursday, March 21, 2024 at 06:01 AM.
Here's what investors need to know about the announcement.
X4 Pharmaceuticals beat estimated earnings by 33.0%, reporting an EPS of $-0.1 versus an estimate of $-0.15.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.14 which was followed by a 5.0% drop in the share price the next day.
To track all earnings releases for X4 Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: XFOR
